What Davidson Kempner Capital Management LP changed, 2014 to 2026
50 quarterly 13F filings, from Q1 2014 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$8.4bn
$2.8bn at Q1 2014
Positions
241
138 at Q1 2014
Top ten weight
42%
43% at Q1 2014
Typical quarterly turnover
about 35%
Estimated from share changes
- Q1 2014: $2.8bn
- Q2 2014: $3.4bn
- Q3 2014: $4.4bn
- Q4 2014: $5.3bn
- Q1 2015: $4.7bn
- Q2 2015: $6.1bn
- Q3 2015: $5.7bn
- Q4 2015: $5.6bn
- Q1 2016: $4.7bn
- Q2 2016: $4.3bn
- Q3 2016: $4.1bn
- Q4 2016: $4.9bn
- Q1 2017: $4.2bn
- Q2 2017: $7.3bn
- Q3 2017: $7.5bn
- Q4 2017: $7.4bn
- Q1 2018: $9.5bn
- Q2 2018: $8.5bn
- Q3 2018: $9.1bn
- Q4 2018: $5.1bn
- Q1 2019: $5.2bn
- Q2 2019: $9.2bn
- Q3 2019: $5.1bn
- Q4 2019: $4.4bn
- Q1 2020: $3.7bn
- Q2 2020: $4.1bn
- Q3 2020: $7.0bn
- Q4 2020: $8.5bn
- Q1 2021: $10.0bn
- Q2 2021: $12.9bn
- Q3 2021: $7.0bn
- Q4 2021: $6.8bn
- Q1 2022: $7.8bn
- Q2 2022: $5.8bn
- Q3 2022: $5.5bn
- Q4 2022: $5.3bn
- Q1 2023: $6.0bn
- Q2 2023: $5.2bn
- Q3 2023: $7.6bn
- Q4 2023: $6.6bn
- Q1 2024: $7.6bn
- Q2 2024: $6.2bn
- Q3 2024: $4.8bn
- Q4 2024: $6.0bn
- Q1 2025: $7.3bn
- Q2 2025: $7.0bn
- Q3 2025: $7.8bn
- Q4 2025: $8.6bn
- Q1 2026: $8.3bn
- Q2 2026: $8.4bn
- Q1 2014: 43%
- Q2 2014: 50%
- Q3 2014: 45%
- Q4 2014: 50%
- Q1 2015: 48%
- Q2 2015: 54%
- Q3 2015: 49%
- Q4 2015: 49%
- Q1 2016: 49%
- Q2 2016: 50%
- Q3 2016: 47%
- Q4 2016: 46%
- Q1 2017: 98%
- Q2 2017: 60%
- Q3 2017: 57%
- Q4 2017: 60%
- Q1 2018: 60%
- Q2 2018: 49%
- Q3 2018: 57%
- Q4 2018: 53%
- Q1 2019: 51%
- Q2 2019: 60%
- Q3 2019: 60%
- Q4 2019: 52%
- Q1 2020: 55%
- Q2 2020: 36%
- Q3 2020: 38%
- Q4 2020: 38%
- Q1 2021: 37%
- Q2 2021: 45%
- Q3 2021: 30%
- Q4 2021: 27%
- Q1 2022: 26%
- Q2 2022: 28%
- Q3 2022: 29%
- Q4 2022: 28%
- Q1 2023: 36%
- Q2 2023: 39%
- Q3 2023: 51%
- Q4 2023: 47%
- Q1 2024: 44%
- Q2 2024: 32%
- Q3 2024: 33%
- Q4 2024: 32%
- Q1 2025: 41%
- Q2 2025: 33%
- Q3 2025: 38%
- Q4 2025: 47%
- Q1 2026: 46%
- Q2 2026: 42%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| iShares Russell 2000 ETF(IWM) | Q3 2014 | $877mQ2 2026 | $877m | |
| Electronic Arts Inc(EA) | Q4 2017 | $750mQ2 2026 | $750m | |
| Spdr S&P 500 Etf Trust(SPY) | Q4 2014 | $1.1bnQ4 2025 | $518m | |
| Invesco QQQ Trust(QQQ) | Q1 2022 | $457mQ2 2022 | $331m | |
| Space Exploration Techn Corp(SPCX)Class A Common Stock | Q2 2026 | $201mQ2 2026 | $201m | |
| iShares IBOXX High Yield ETF(HYG) | Q1 2026 | $200mQ2 2026 | $200m | |
| Echostar Corp(ECHO)Class A | Q3 2025 | $199mQ2 2026 | $199m | |
| Arko Corp(ARKO) | Q4 2020 | $237mQ1 2021 | $186m | |
| MKS Inc.Note 1.250% 6/0 | Q1 2026 | $146mQ2 2026 | $146m | |
| Alibaba Group HLDG LTDNote 0.500% 6/0 | Q2 2025 | $202mQ3 2025 | $142m | |
| Uber Technologies IncNote 0.875%12/0 | Q4 2024 | $129mQ3 2025 | $120m | |
| Rivian Automotive IncNote 4.625% 3/1 | Q1 2024 | $118mQ2 2026 | $118m | |
| NXP Semiconductors N V(NXPI) | Q2 2016 | $1.9bnQ1 2018 | Soldlast listed Q1 2018 | |
| Aetna Inc New | Q2 2015 | $1.6bnQ3 2018 | Soldlast listed Q3 2018 | |
| Activision Blizzard Inc | Q1 2015 | $1.4bnQ3 2023 | Soldlast listed Q3 2023 | |
| Spdr S&P 500 Etf Trust(SPY) | Q2 2018 | $1.4bnQ1 2026 | Soldlast listed Q1 2026 | |
| Altaba Inc | Q2 2017 | $1.1bnQ2 2019 | Soldlast listed Q3 2019 | |
| Reynolds American Inc | Q1 2014 | $1.1bnQ2 2017 | Soldlast listed Q2 2017 | |
| Allergan PLC | Q4 2015 | $1.0bnQ4 2019 | Soldlast listed Q1 2020 | |
| Alexion Pharmaceuticals Inc | Q2 2015 | $1.0bnQ2 2021 | Soldlast listed Q2 2021 |
Quarter by quarter
Q3 2019: $5.1bn across 163 positions
Against Q2 2019: 77 new, 17 added to, 33 trimmed, 91 sold out, across all 163 positions.
Turnover about 26% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Allergan PLC+$630m
- Celgene Corp+$103m
- Zayo Group HLDGS Inc+$50m
- Tyson Foods Inc (TSN)+$48m
- Dollar Tree Inc (DLTR)+$38m
- Hilton Grand Vacations Inc (HGV)+$30m
- Sanderson Farms Inc+$26m
- Centene Corp Del (CNC)+$21m
Largest reductions
- Pg&e Corp (PCG)-$82m
- Cypress Semiconductor Corp-$59m
- T-mobile US Inc (TMUS)-$51m
- Twitter Inc-$36m
- Vistra Energy Corp (VST)-$29m
- Weibo Corp-$27m
- Ashland Global HLDGS Inc (ASH)-$23m
- Smartsheet Inc-$17m
Opened
- Symantec Corp$87m
- Alder Biopharmaceuticals Inc$62m
- Activision Blizzard Inc$57m
- Momo Inc$45m
- Iheartmedia Inc (IHRT)$40m
Sold out
- Anadarko Pete Corpwas $1.3bn
- First Data Corp Newwas $746m
- Red Hat Incwas $739m
- Array Biopharma Incwas $283m
- Worldpay Incwas $169m
- Tableau Software Incwas $76m
- Restaurant Brands Intl Inc (QSR)was $71m
- Caesars Entmt Corpwas $71m
Largest positions, Q3 2019
The largest 25 of 163 reported positions.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Celgene Corp | $809m | 15.9% | Added |
| Allergan PLC | $809m | 15.9% | Added |
| Altaba Inc | $398m | 7.8% | Added |
| Vistra Energy Corp (VST) | $254m | 5.0% | Trimmed |
| Zayo Group HLDGS Inc | $230m | 4.5% | Added |
| Tyson Foods Inc (TSN) | $202m | 4.0% | Added |
| Tenet Healthcare Corp (THC) | $108m | 2.1% | Trimmed |
| Symantec Corp | $87m | 1.7% | New |
| Dollar Tree Inc (DLTR) | $80m | 1.6% | Added |
| Avaya HLDGS Corp | $75m | 1.5% | Held |
| Alder Biopharmaceuticals Inc | $62m | 1.2% | New |
| Activision Blizzard Inc | $57m | 1.1% | New |
| Pg&e Corp (PCG) | $54m | 1.1% | Trimmed |
| Centene Corp Del (CNC) | $54m | 1.1% | Added |
| Contura Energy Inc | $52m | 1.0% | Held |
| Cypress Semiconductor Corp | $52m | 1.0% | Trimmed |
| Tesla Inc | $46m | 0.9% | Added |
| Disney Walt Co (DIS) | $46m | 0.9% | Added |
| Momo Inc | $45m | 0.9% | New |
| T-mobile US Inc (TMUS) | $44m | 0.9% | Trimmed |
| Altice USA Inc (OPTU) | $44m | 0.9% | Trimmed |
| Clear Channel Outdoor HLDGS (CCO) | $43m | 0.8% | Held |
| Hilton Grand Vacations Inc (HGV) | $42m | 0.8% | Added |
| Radius Health Inc | $41m | 0.8% | Held |
| Iheartmedia Inc (IHRT) | $40m | 0.8% | New |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| Soros Fund Management LLC | 12% | 45 | Compare | |
| Fidelity (FMR LLC) | at least 9.9% | 48 | Compare | |
| Neuberger Berman Group LLC | at least 9.7% | 49 | Compare | |
| Janus Henderson Group Ltd | at least 9.6% | 46 | Compare | |
| Farallon Capital Management LLC | 9.3% | 6 | Compare | |
| T. Rowe Price Associates Inc | at least 9.2% | 47 | Compare | |
| Wellington Management Group LLP | at least 8.8% | 45 | Compare | |
| Capital Research Global Investors | 8.6% | 45 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Davidson Kempner Capital Management LP | $8.4bn | 13F-HR | |
| Q1 2026 | Davidson Kempner Capital Management LP | $8.3bn | 2 | 13F-HR |
| Q4 2025 | Davidson Kempner Capital Management LP | $8.6bn | 4 | 13F-HR |
| Q3 2025 | Davidson Kempner Capital Management LP | $7.8bn | 6 | 13F-HR |
| Q2 2025 | Davidson Kempner Capital Management LP | $7.0bn | 5 | 13F-HR |
| Q1 2025 | Davidson Kempner Capital Management LP | $7.3bn | 8 | 13F-HR |
| Q4 2024 | Davidson Kempner Capital Management LP | $6.0bn | 10 | 13F-HR |
| Q3 2024 | Davidson Kempner Capital Management LP | $4.8bn | 7 | 13F-HR |
| Q2 2024 | Davidson Kempner Capital Management LP | $6.2bn | 7 | 13F-HR |
| Q1 2024 | Davidson Kempner Capital Management LP | $7.6bn | 5 | 13F-HR |
| Q4 2023 | Davidson Kempner Capital Management LP | $6.6bn | 6 | 13F-HR |
| Q3 2023 | Davidson Kempner Capital Management LP | $7.6bn | 6 | 13F-HR |
| Q2 2023 | Davidson Kempner Capital Management LP | $5.2bn | 7 | 13F-HR |
| Q1 2023 | Davidson Kempner Capital Management LP | $6.0bn | 5 | 13F-HR |
| Q4 2022 | Davidson Kempner Capital Management LP | $5.3bn | 6 | 13F-HR |
| Q3 2022 | Davidson Kempner Capital Management LP | $5.5bn | 8 | 13F-HR |
| Q2 2022 | Davidson Kempner Capital Management LP | $5.8bn | 5 | 13F-HR |
| Q1 2022 | Davidson Kempner Capital Management LP | $7.8bn | 6 | 13F-HR |
| Q4 2021 | Davidson Kempner Capital Management LP | $6.8bn | 6 | 13F-HR |
| Q3 2021 | Davidson Kempner Capital Management LP | $7.0bn | 5 | 13F-HR |
| Q2 2021 | Davidson Kempner Capital Management LP | $12.9bn | 8 | 13F-HR |
| Q1 2021 | Davidson Kempner Capital Management LP | $10.0bn | 8 | 13F-HR |
| Q4 2020 | Davidson Kempner Capital Management LP | $8.5bn | 7 | 13F-HR |
| Q3 2020 | Davidson Kempner Capital Management LP | $7.0bn | 7 | 13F-HR |
| Q2 2020 | Davidson Kempner Capital Management LP | $4.1bn | 5 | 13F-HR |
| Q1 2020 | Davidson Kempner Capital Management LP | $3.7bn | 7 | 13F-HR |
| Q4 2019 | Davidson Kempner Capital Management LP | $4.4bn | 5 | 13F-HR |
| Q3 2019 | Davidson Kempner Capital Management LP | $5.1bn | 6 | 13F-HR |
| Q2 2019 | Davidson Kempner Capital Management LP | $9.2bn | 6 | 13F-HR |
| Q1 2019 | Davidson Kempner Capital Management LP | $5.2bn | 7 | 13F-HR |
| Q4 2018 | Davidson Kempner Capital Management LP | $5.1bn | 3 | 13F-HR |
| Q3 2018 | Davidson Kempner Capital Management LP | $9.1bn | 6 | 13F-HR |
| Q2 2018 | Davidson Kempner Capital Management LP | $8.5bn | 7 | 13F-HR |
| Q1 2018 | Davidson Kempner Capital Management LP | $9.5bn | 9 | 13F-HR |
| Q4 2017 | Davidson Kempner Capital Management LP | $7.4bn | 7 | 13F-HR |
| Q3 2017 | Davidson Kempner Capital Management LP | $7.5bn | 11 | 13F-HR |
| Q2 2017 | Davidson Kempner Capital Management LP | $7.3bn | 10 | 13F-HR |
| Q1 2017 | Davidson Kempner Capital Management LP | $4.2bn | 11 | 13F-HR |
| Q4 2016 | Davidson Kempner Capital Management LP | $4.9bn | 12 | 13F-HR |
| Q3 2016 | Davidson Kempner Capital Management LP | $4.1bn | 11 | 13F-HR |
| Q2 2016 | Davidson Kempner Capital Management LP | $4.3bn | 9 | 13F-HR |
| Q1 2016 | Davidson Kempner Capital Management LP | $4.7bn | 11 | 13F-HR |
| Q4 2015 | Davidson Kempner Capital Management LP | $5.6bn | 11 | 13F-HR |
| Q3 2015 | Davidson Kempner Capital Management LP | $5.7bn | 9 | 13F-HR |
| Q2 2015 | Davidson Kempner Capital Management LP | $6.1bn | 8 | 13F-HR |
| Q1 2015 | Davidson Kempner Capital Management LP | $4.7bn | 8 | 13F-HR |
| Q4 2014 | Davidson Kempner Capital Management LP | $5.3bn | 8 | 13F-HR |
| Q3 2014 | Davidson Kempner Capital Management LP | $4.4bn | 10 | 13F-HR |
| Q2 2014 | Davidson Kempner Capital Management LP | $3.4bn | 8 | 13F-HR |
| Q1 2014 | Davidson Kempner Capital Management LP | $2.8bn | 6 | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More